Development of monoclonal antibodies (MAbs) to feline interferon (fIFN)-γ as tools to evaluate cellular immune responses to feline infectious peritonitis virus (FIPV)

Journal of Feline Medicine and Surgery

Volumn 13, Issue 6, 2011, Pages 427-435

  Satoh, Ryoichi ^a   Kaku, Ayumi ^a   Satomura, Megumi ^a   Kohori, Michiyo ^a   Noura, Kanako ^a   Furukawa, Tomoko ^a   Kotake, Masako ^a   Takano, Tomomi ^a   Hohdatsu, Tsutomu ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MONOCLONAL ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; CAT; CELLULAR IMMUNITY; CORONAVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FELINE INFECTIOUS PERITONITIS; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; METHODOLOGY; MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; CATS; CORONAVIRUS, FELINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FELINE INFECTIOUS PERITONITIS; FEMALE; FLOW CYTOMETRY; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C;

CORONAVIRUS; FELIDAE; FELINE INFECTIOUS PERITONITIS VIRUS;

EID: 79956134888     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2011.01.008     Document Type: Article

References (45)

1. Hohdatsu T., Okada S., Koyama H. Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses. Arch Virol 1991, 117:85-95.
2. Motokawa K., Hohdatsu T., Aizawa C., Koyama H., Hashimoto H. Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type I. Arch Virol 1995, 140:469-480.
3. Motokawa K., Hohdatsu T., Hashimoto H., Koyama H. Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol Immunol 1996, 40:425-433.
4. Pedersen N.C., Boyle J.F., Floyd K., Fudge A., Barker J. An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am J Vet Res 1981, 42:368-377.
5. Pedersen N.C. A review of feline infectious peritonitis virus infection: 1963-2008. J Feline Med Surg 2009, 11:225-258.
6. Pedersen N.C., Allen C.E., Lyons L.A. Pathogenesis of feline enteric coronavirus infection. J Feline Med Surg 2008, 10:529-541.
7. Poland A.M., Vennema H., Foley J.E., Pedersen N.C. Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J Clin Microbiol 1996, 34:3180-3184.
8. Vennema H., Poland A., Foley J., Pedersen N.C. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 1998, 243:150-157.
9. Kipar A., May H., Menger S., Weber M., Leukert W., Reinacher M. Morphologic features and development of granulomatous vasculitis in feline infectious peritonitis. Vet Pathol 2005, 42:321-330.
10. Barlough J.E., Stoddart C.A., Sorresso G.P., Jacobson R.H., Scott F.W. Experimental inoculation of cats with canine coronavirus and subsequent challenge with feline infectious peritonitis virus. Lab Anim Sci 1984, 34:592-597.
11. Pedersen N.C., Black J.W. Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am J Vet Res 1983, 44:229-234.
12. Pedersen N.C., Evermann J.F., Mckeirnan A.J., Ott R.L. Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am J Vet Res 1984, 45:2580-2585.
13. Stoddart C.A., Barlough J.E., Baldwin C.A., Scott F.W. Attempted immunisation of cats against feline infectious peritonitis using canine coronavirus. Res Vet Sci 1988, 45:383-388.
14. Woods R.D., Pedersen N.C. Cross-protection studies between feline infectious peritonitis and porcine transmissible gastroenteritis viruses. Vet Microbiol 1979, 4:11-16.
15. Pedersen N.C., Boyle J.F. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res 1980, 41:868-876.
16. Weiss R.C., Scott F.W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis 1981, 4:175-189.
17. Gelain M.E., Meli M., Paltrinieri S. Whole blood cytokine profiles in cats infected by feline coronavirus and healthy non-FCoV infected specific pathogen-free cats. J Feline Med Surg 2006, 8:389-399.
18. Kiss I., Poland A.M., Pedersen N.C. Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)-UCD1 and challenge-exposed with virulent FIPV-UCD8. J Feline Med Surg 2004, 6:89-97.
19. Weiss R.C., Cox N.R. Delayed-type hypersensitivity skin response associated with feline infectious peritonitis in two cats. Res Vet Sci 1988, 44:396-398.
20. Weiss R.C., Cox N.R. Evaluation of immunity to feline infectious peritonitis in cats with cutaneous viral-induced delayed hypersensitivity. Vet Immunol Immunopathol 1989, 21:293-309.
21. Stoddart M.E., Gaskell R.M., Harbour D.A., Gaskell C.J. Virus shedding and immune responses in cats inoculated with cell culture-adapted feline infectious peritonitis virus. Vet Microbiol 1988, 16:145-158.
22. Bauer R.M., Olsen R.G. Parameters of production and partial characterization of feline interleukin 2. Vet Immunol Immunopathol 1988, 19:173-183.
23. Mateu de Antonio E., Husmann R.J., Hansen R., et al. Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen. Vet Immunol Immunopathol 1998, 61:265-277.
24. Surcel H.M., Troye-Blomberg M., Paulie S., et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994, 81:171-176.
25. Jung T., Schauer U., Heusser C., Neumann C., Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993, 159:197-207.
26. Pitcher C.J., Quittner C., Peterson D.M., et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 1999, 5:518-525.
27. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
28. Takano T., Kawakami C., Yamada S., Satoh R., Hohdatsu T. Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection. J Vet Med Sci 2008, 70:1315-1321.
29. Takano T., Katada Y., Moritoh S., et al. Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary. J Gen Virol 2008, 89:1025-1029.
30. Masuda K., Sakaguchi M., Saito S., et al. In vivo and in vitro tests showing sensitization to Japanese cedar (Cryptomeria japonica) pollen allergen in atopic dogs. J Vet Med Sci 2000, 62:995-1000.
31. Kemp K., Theander T.G., Hviid L., Garfar A., Kharazmi A., Kemp M. Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis. Scand J Immunol 1999, 49:655-659.
32. Pathan A.A., Wilkinson K.A., Klenerman P., et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001, 167:5217-5225.
33. Shankar P., Russo M., Harnisch B., Patterson M., Skolnik P., Lieberman J. Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection. Blood 2000, 96:3094-3101.
34. Harari A., Vallelian F., Meylan P.R., Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005, 174:1037-1045.
35. van Lier R.A., ten Berge I.J., Gamadia L.E. Human CD8+ T-cell differentiation in response to viruses. Nat Rev Immunol 2003, 3:931-939.
36. Wherry E.J., Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004, 78:5535-5545.
37. Wills M.R., Okecha G., Weekes M.P., Gandhi M.K., Sissons P.J., Carmichael A.J. Identification of naive or antigen-experienced human CD8+ T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8+ T cell response. J Immunol 2002, 168:5455-5464.
38. Peng H., Yang L.T., Li J., et al. Human memory T cell responses to SARS-CoV E protein. Microbes Infect 2006, 8:2424-2431.
39. Peng H., Yang L.T., Wang L.Y., et al. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 2006, 351:466-475.
40. Yang L.T., Peng H., Zhu Z.L., et al. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clin Immunol 2006, 120:171-178.
41. Chen H., Hou J., Jiang X., et al. Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. J Immunol 2005, 175:591-598.
42. Zhou M., Xu D., Li X., et al. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. J Immunol 2006, 177:2138-2145.
43. Tsao Y.P., Lin J.Y., Jan J.T., et al. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochem Biophys Res Commun 2006, 344:63-71.
44. Wang B., Chen H., Jiang X., et al. Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein. Blood 2004, 104:200-206.
45. Wang Y.D., Sin W.Y., Xu G.B., et al. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. J Virol 2004, 78:5612-5618.